PLX Operating Cash Flow Growth

Protalix Biotherapeutics Inc · Operating Cash Flow Growth

PLX logo

PLX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported552.07%
PLX TTM Cash from Operations YoY % (66.67% → 552.07%)
High-resolution chart · PNG

PLX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Protalix Biotherapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
552.0729%
2,738.1119%
-238.2638%
-221.1887%
19.1529%
-109.7478%
758.1184%
210.0213%
72.4085%
126.4694%
94.728%
72.6161%
51.1711%
-253.0096%
-143.0724%
-115.5318%
-39.2482%
78.2118%
60.6029%
42.6876%
33.809%
-50.1276%
-34.859%
-13.0521%
-677.8015%
-242.5335%
-150.0387%
-242.0373%
72.7775%
48.9573%
22.5335%
139.6655%
62.8908%
64.4616%
68.8641%
-22.0324%
17.7573%
-12.4091%
-32.1776%
-13.1062%
-29.1916%
-0.4605%
17.0657%
13.2011%
5.8525%
6.9541%
4.4759%
-21.0004%
-16.3745%
-1,001.3858%
-4,927.2441%
-208.9254%
-201.9581%
89.6764%
102.6941%
68.7943%
70.1531%
22.8131%
38.7219%
-187.1152%
-180.4819%
-180.7612%
-186.5293%
269.6835%
284.8959%
328.0869%
377.5648%
4.1449%
-37.3112%
-59.0452%
-53.2683%
-53.0841%
-30.4964%
-45.574%
-105.2445%
-7,007.5366%
-11,701.47%
-8,129.5306%
-6,924.4912%
-90.0768%
21.2227%
27.9092%
56.8922%
51.8188%
30.7237%
13.8698%
-23.0045%
-27.5847%
-9.5919%
-15.1848%
6.7564%
90.4052%
90.3257%
82.5741%
81.4314%
-315.2569%
-321.4874%
-1,278.0182%
-1,386.4578%
341.0494%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.